Document:

Exhibit
10.11

 

AMENDMENT
TO FIRST AMENDMENT AGREEMENT entered into as of the 3rd day of December, 2015 (the “Amendment”).

 

	BETWEEN:	KNIGHT
    THERAPEUTICS (BARBADOS) INC., a corporation formed under the laws of Barbados;
	 	(hereinafter
    called the “Lender”)
	 	 
	AND:	SYNERGY
    CHC CORP., a corporation formed under the laws of the State of Nevada;
	 	(hereinafter
    called the “Synergy”)

 

WHEREAS
Synergy (then known as Synergy Strips Corp.) and the Lender are parties to that certain loan agreement (as amended by the First Amendment,
the “Loan Agreement”) made as of the 21st day of January, 2015, pursuant to which the Lender has extended
a loan to Synergy in the principal amount of Six Million United States Dollars (US$6,000,000) as amended by a first amendment to the
loan agreement made as of November 12, 2015 (the “First Amendment”) pursuant to which the Lender has extended an additional
loan to Synergy in the principal amount of Five Million Five Hundred Thousand United States Dollars (US$5,500,000) (the “Additional
Loan”);

 

WHEREAS
the Lender and Synergy desire to amend the First Amendment to, inter alia, modify the conditions precedent for the second
tranche of the Additional Loan;

 

NOW,
THEREFORE, IN CONSIDERATION of these presents and of the mutual covenants hereinafter contained, the parties have agreed as follows:

 

Article
1

interpretation

 

	1.1	Capitalized
    Terms

 

In
this Amendment, capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Loan Agreement.

 

Article
2

amendments

 

	2.1	Amendments
    to the First Amendment

 

The
Borrower and the Lender hereby agree to amend the First Agreement as follows:

 

	 	2.1.1	Section
    2.1.1 of the First Amendment is hereby amended by inserting the following definition:
	 	 	 
	 	 	“Amendment
    and Confirmation Agreement” means that certain agreement among the Lender, Synergy, Nomad and Breakthrough by which Nomad
    and Breakthrough confirm that the terms of the distribution, license and supply agreement dated January 22, 2015 between Synergy
    and the Lender apply to them and by which the parties amend certain provisions of such distribution, license and supply agreement;

 

	 	2.1.2	Section
    2.1.1 of the First Amendment is hereby amended by deleting the definition of “Lender’s Nomad Distribution Agreement”.
	 	 	 
	 	2.1.3	Section
    3.2.5 of the First Amendment is hereby amended to replace “Lender’s Nomad Distribution Agreement” by “Amendment
    and Confirmation Agreement”.
	 	 	 
	 	2.1.4	Article
    3 of the First Amendment is hereby amended by adding the following:

 

    	 

    	 

    

 

	 	3.5	Distribution
    Agreement

 

	 	 	The
    Lender, Nomad and Borrower shall enter into, execute and deliver a distribution agreement within thirty (30) days of the disbursement
    of the second tranche of the Additional Loan with the following terms and conditions:
	 	 	 
	 	(a)	Lender
    and/or its affiliates shall grant to Nomad non-exclusive distribution rights for “Flat Tummy Tea” products in the Territory
    for direct to consumer sales; and
	 	 	 
	 	(b)	Nomad
    shall buy its “Flat Tummy Tea” products in the Territory for direct to consumer sales under the distribution agreement
    on an exclusive basis from the Lender and/or its affiliates at cost of goods plus 60% of gross sales.

 

	 	2.1.5	From
    and after the date hereof, (i) all references in the First Amendment to “this First Amendment” shall mean the First Amendment
    as amended by this Amendment, and as may otherwise be amended, restated, supplemented or otherwise modified from time to time, and
    (ii) all references in the other Loan Documents to the “Loan Agreement” (or words of similar import) shall be deemed
    to be references to the Loan Agreement as amended by the First Amendment as amended by this Amendment, and as may otherwise be amended,
    restated, supplemented or otherwise modified from time to time. All references in any of the Loan Documents to the “Loan Documents”
    shall mean the Loan Documents as amended by this Amendment and as may otherwise be amended restated, supplemented or otherwise modified
    from time to time.
	 	 	 
	 	2.1.6	Except
    as expressly amended by this Amendment, all other provisions of the First Amendment and the Transaction Documents not specifically
    amended hereby shall remain unchanged and in full force and effect.

 

Article
3

MISCELLANEOUS

 

	3.1	Further
    Assurances

 

Each
of the Borrower and the Lender shall, from time to time hereafter and upon any reasonable request of the other party, execute and deliver
such further agreements and documents and do all such other acts and things as may be necessary or appropriate to give effect to the
foregoing.

 

	3.2	Time
    of the Essence

 

Time
shall be of the essence of this Amendment.

 

	3.3	Severability

 

If
any provision of this Amendment is found by final judgment of a court of competent jurisdiction to be invalid or unenforceable in whole
or in part, such provision (or part thereof, as the case may be) shall be severable and such finding shall not affect the validity or
enforceability of the remainder of such provision or of any other provision hereof.

 

	3.4	Enurement

 

This
Amendment shall enure to the benefit of and be binding upon the parties hereto and their permitted assigns.

 

	3.5	Counterparts

 

This
Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all of which, taken together, shall
constitute one and the same instrument.

 

	3.6	Paramountcy

 

In
the event of any conflict or inconsistency between the terms and conditions of this Amendment and the terms and conditions of any other
Transaction Document, including the Loan Agreement and the First Amendment, the terms and conditions of this Amendment shall prevail
and be paramount to the extent of such conflict or inconsistency.

 

	3.7	Governing
    Law

 

This
Amendment will be governed by and construed in accordance with the laws of the Province of Quebec and the laws of Canada applicable therein.

 

	3.8	Language

 

The
parties acknowledge that they have requested that this Amendment and all ancillary documents be drawn up in the English language only.
Les parties reconnaissent avoir exigé que cette convention ainsi que tous les documents y reliés soient rédigés
en anglais seulement.

 

    	 

    	 

    

 

IN
WITNESS WHEREOF the parties hereto have duly executed this Amendment as of the date and at the place first hereinabove set forth.

 

	 	KNIGHT
    THERAPEUTICS (BARBADOS) INC.
	 	 
	 	By:	/s/
    Michael Loustric
	 	Name:	Michael
    Loustric 
	 	Title:	President
	 	 	 
	 	SYNERGY
    CHC CORP.
	 	 
	 	By:	/s/
    Jack Ross
	 	Name:	Jack
    Ross
	 	Title:
    	Chief
    Executive OfficerExhibit 10.12 

 

AMENDMENT
AND CONFIRMATION AGREEMENT

 

THIS
AGREEMENT, effective December 3rd, 2015, by and among KNIGHT THERAPEUTICS (BARBADOS) INC. (“Knight”),
a corporation incorporated under the laws of Barbados, NOMAD CHOICE PTY LTD. (“Nomad”), a corporation
formed under the laws of Australia, and SYNERGY CHC CORP. (“Synergy”), a corporation formed under the
laws of the State of Nevada, and BREAKTHROUGH PRODUCTS, INC. (“Breakthrough”), a corporation formed under the
laws of Delaware.

 

WHEREAS
Synergy and Knight are parties to that certain distribution, license and supply agreement dated January 22, 2015 as may be amended,
supplemented or restated from time to time (the “DLS Agreement”);

 

WHEREAS
pursuant to the DLS Agreement, Synergy, for itself and on behalf of its Affiliates, has named Knight its exclusive distributor of
Licensed Products in the Territory;

 

WHEREAS
Synergy has acquired all of the shares of Nomad effective November 16, 2015 and, as and from that date, Nomad became an Affiliate;

 

WHEREAS
Synergy has acquired all of the shares of Breakthrough effective November 12, 2015 and as and from that date, Breakthrough became
an Affiliate;

 

WHEREAS
the parties wish to confirm that the terms and conditions of the DLS Agreement apply to Nomad and Breakthrough effective from the
dates each became an Affiliate;

 

WHEREAS
the parties wish to confirm certain amendments to the DLS Agreement;

 

NOW
THEREFORE in consideration of the mutual promises and covenants contained herein, the Parties, intending to be legally bound, agree
as follows:

 

	1	DEFINITIONS
	 	 
	1.1	Definitions.
    Unless the context otherwise indicates, defined terms used in this Agreement shall have the meaning ascribed thereto in the DLS Agreement.
	 	 
	2	GRANT
    OF RIGHTS
	 	 
	2.1	Each
    of Nomad and Breakthrough hereby confirms that it is subject to the terms and conditions of the DLS Agreement, as hereby amended,
    as if it were an original signatory thereto.
	 	 
	2.2	The
    DLS Agreement is hereby amended by replacing the definition of “Licensed Product” as follows:

 

“(i)
with respect to Synergy means FocusFactor, FocusFactor Kids, Synergy Strips and all Improvements thereto, and (ii) with respect to Nomad,
Breakthrough and any other Subsidiary of Synergy means all of the their present and future products (including with respect to Nomad
“Flat Tummy Tea” and with respect to Breakthrough “urgentRX”)”.

 

	2.3	The
    DLS Agreement is hereby amended by replacing the definition of “Territory” as follows:

 

“Territory
(i) means Canada, Israel, Romania, Russia and each of the countries within Sub-Saharan Africa.”

 

	2.4	The
    DLS Agreement is hereby amended by deleting (i) Section 11 thereof and (ii) all references in the DLS Agreement to the defined term
    “Additional Territory”.
	 	 
	2.5	Section
    9.3 of the DLS Agreement is deleted and replaced with the following:

 

“9.3
Termination of Knight. Knight may terminate this Agreement in whole or in part (including with respect to a particular Licensed
Product and/or Territory or a particular Territory in respect of a particular Licensed Product) by notice in writing given not less than
sixty (60) days prior to the intended termination date.”

 

    	 

    	 

    

 

	3	OTHER
    PROVISIONS
	 	 
	3.1	Waiver.
    No failure to exercise and no delay in exercising any right or remedy hereunder shall operate as a waiver thereof. Any waiver granted
    hereunder shall only be applicable the specific acts covered thereby and shall not apply to any subsequent events, acts, or circumstances.
	 	 
	3.2	Severability.
    In the event any portion of this Agreement shall be held illegal, void or ineffective, the remaining portion hereof shall remain
    in full force and effect. If any of the terms or provisions of this Agreement are in conflict with any applicable statute or rule
    of law, then such terms or provisions shall be deemed inoperative to the extent that they may conflict therewith and shall be deemed
    to be modified to conform with such statute or rule of law.
	 	 
	3.3	Governing
    Law. This Agreement all disputes arising out of or relating to this Agreement, or the performance, enforcement, breach or termination
    hereof or thereof, and any remedies relating thereto, shall be construed, governed by and interpreted in accordance with the laws
    of the State of New York.
	 	 
	3.4	Counterparts.
    This Agreement may be executed in any number of counterparts, each of which shall be considered one and the same Agreement and shall
    become effective when a counterpart hereof has been signed by each of the Parties and delivered to the other Party.
	 	 
	3.5	Time
    of Essence. Time shall be of the essence of this Agreement and of each provision hereof.

 

    	 

    	 

    

 

In
witness whereof, the parties have signed this Agreement.

 

	 	KNIGHT THERAPEUTICS (BARBADOS) INC.

 

	 	By:	/s/
    Michael Loustric
	 	Name:	Michael
    Loustric
	 	Title:	President

 

	 	NOMAD CHOICE PTY LTD.

 

	 	By:	/s/
    Jack Ross
	 	Name:	Jack
    Ross
	 	Title:	Chief
    Executive Officer

 

	 	SYNERGY CHC CORP.

 

	 	By:	/s/
    Jack Ross
	 	Name:	Jack
    Ross
	 	Title:	Chief
    Executive Officer

 

	 	BREAKTHROUGH PRODUCTS, INC.

 

	 	By:	/s/
    Jack Ross
	 	Name:	Jack
    Ross
	 	Title:	Chief
    Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]